A bullish market and another quant upgrade could push BSX past our $31 target.
- Capital Cube•4 days ago
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Boston Scientific Corp. a score of 41. Our analysis is based on comparing Boston Scientific Corp. with the following peers – Edwards Lifesciences Corporation, C. R. Bard, Inc., Stryker Corporation, Merit Medical Systems, Inc., Medtronic plc, Teleflex Incorporated, AngioDynamics, Inc., Spectranetics Corporation and CONMED Corporation (EW-US, BCR-US, ... Read more (Read more...)
- Zacks•4 days ago
Boston Scientific Corporation (BSX) is scheduled to report first-quarter 2017 results before the opening bell on Apr 27.
BSX : Summary for Boston Scientific Corporation C - Yahoo Finance
Boston Scientific Corporation (BSX)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||25.65 - 25.91|
|52 Week Range||19.59 - 25.91|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||102.96|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|